CORRECTED-UPDATE 1-Roche's Tecentriq wins FDA approval as first-line therapy for some lung cancer forms (May 18)
May 20, 2020 at 11:14 AM EDT
Swiss drugmaker Roche Holding AG's Genentech unit said on Monday the U.S. Food and Drug Administration has approved Tecentriq as a standalone therapy for an advanced form of lung cancer.
